| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8650923 | American Heart Journal | 2018 | 23 Pages |
Abstract
According to our meta-analysis TPC plus antiplatelets was superior in terms of stroke prevention when compared to Med-Tx. Furthermore, patients with moderate to severe shunts and those younger than 45 years of age were found to benefit most from TPC.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Markus MD, Ann-Kathrin MD, David MD, Jonathan Curio, Haitham S. Al-Hindwan, Johan Bäckemo Johansson, Friedrich MD, Andreas MD, Geraldine MD, Ulf MD,